4 Analysts Assess Select Medical Hldgs: What You Need To Know

During the last three months, 4 analysts shared their evaluations of Select Medical Hldgs SEM, revealing diverse outlooks from bullish to bearish.

The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.

Insights from analysts' 12-month price targets are revealed, presenting an average target of $41.0, a high estimate of $48.00, and a low estimate of $21.00. This current average has decreased by 6.82% from the previous average price target of $44.00.

Interpreting Analyst Ratings: A Closer Look

An in-depth analysis of recent analyst actions unveils how financial experts perceive Select Medical Hldgs. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Key Insights:

• Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Select Medical Hldgs. This offers insight into analysts' perspectives on the current state of the company.
• Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Select Medical Hldgs compared to the broader market.
• Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Select Medical Hldgs's stock. This examination reveals shifts in analysts' expectations over time.

Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Select Medical Hldgs's market standing. Stay informed and make well-considered decisions with our Ratings Table.

Stay up to date on Select Medical Hldgs analyst ratings.

Delving into Select Medical Hldgs's Background

Select Medical Holdings Corp is a healthcare company that operates through four main segments: critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and Concentra institutions. Critical illness recovery hospitals and rehabilitation centres are designed for patients requiring extended recovery time with medical services. These two sectors combined compose roughly half of the total revenue and include over 103 critical illness recovery hospitals and inpatient rehab facilities. The outpatient rehabilitation segment includes over 1,928 rehabilitation clinics. The Concentra segment includes over 540 occupational health centers and 147 onsite clinics. The company is headquartered in Pennsylvania, and it operates across the United States.

Select Medical Hldgs's Financial Performance

Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.

Revenue Growth: Select Medical Hldgs displayed positive results in 3 months. As of 30 September, 2024, the company achieved a solid revenue growth rate of approximately 5.73%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.

Net Margin: Select Medical Hldgs's net margin excels beyond industry benchmarks, reaching 3.04%. This signifies efficient cost management and strong financial health.

Return on Equity (ROE): Select Medical Hldgs's ROE excels beyond industry benchmarks, reaching 3.21%. This signifies robust financial management and efficient use of shareholder equity capital.

Return on Assets (ROA): Select Medical Hldgs's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 0.67% ROA, the company effectively utilizes its assets for optimal returns.

Debt Management: Select Medical Hldgs's debt-to-equity ratio is below the industry average at 2.39, reflecting a lower dependency on debt financing and a more conservative financial approach.

How Are Analyst Ratings Determined?

Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.

Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.

Breaking: Wall Street's Next Big Mover

Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details.

This article was generated by Benzinga's automated content engine and reviewed by an editor.